Millendo Therapeutics, Inc. announced that on January 22, 2021, the Board appointed Louis J. Arcudi III as the President and Principal Executive Officer, effective February 1, 2021, at which time he will also join the Company's Board. Mr. Arcudi has served as the Chief Financial Officer of the Company and its predecessor since November 2018. In connection with the above appointment of Mr. Arcudi, Julia C. Owens, Ph.D. will step down from her role as President and Principal Executive Officer, effective January 31, 2021.